Drug Chatter -- Tracking biopharma stock chatter

Profile for Celldex Therapeutics, Inc. (CLDX)

« Back to company index

CLDX Chatter Timeline

Stock Ticker for CLDX

Most Active Tweeters for CLDX

UserTweets
@stocknewstimes 9
@SleekMoneycom 8
@TickerReport 7
@ConsumerFeed 6
@dispatchtribune 5

Recent Tweets for CLDX

AmericanBanking @AmericanBanking
Celldex Therapeutics, Inc. $CLDX Expected to Post Earnings of -$0.20 Per Share https://t.co/ymz5dcZZ3K
November 19th 2017, 5:11pm
intercooleronli @intercooleronli
Celldex Therapeutics, Inc. $CLDX Expected to Post Earnings of -$0.20 Per Share https://t.co/Nv63fzsImA
November 19th 2017, 5:11pm
TheMarketsDaily @TheMarketsDaily
Celldex Therapeutics, Inc. $CLDX Expected to Post Earnings of -$0.20 Per Share https://t.co/aBN3WrYTnB
November 19th 2017, 5:11pm
CFinancialNews @CFinancialNews
Celldex Therapeutics, Inc. $CLDX Expected to Post Earnings of -$0.20 Per Share https://t.co/GzDulPM0DZ
November 19th 2017, 5:11pm
ConsumerFeed @ConsumerFeed
Celldex Therapeutics, Inc. $CLDX Expected to Post Earnings of -$0.20 Per Share https://t.co/odaaQhGfCk #acn
November 19th 2017, 5:11pm
stockcharts247 @stockcharts247
CLDX 2.91   -  Updated: 11-19-2017 $CLDX Last Trade: 11/17/2017 Last 2.91   -  Open 2.84 Previous Clos https://t.co/ZQ7FTOna7r
November 19th 2017, 11:11am
SleekMoneycom @SleekMoneycom
Leerink Swann Comments on Celldex Therapeutics, Inc.’s FY2017 Earnings $CLDX https://t.co/A95Dykw1DP
November 19th 2017, 7:11am
stocknewstimes @stocknewstimes
Leerink Swann Comments on Celldex Therapeutics, Inc.’s FY2017 Earnings $CLDX https://t.co/yOYGdSxDbY
November 19th 2017, 7:11am
TickerReport @TickerReport
Northern Trust Corp Increases Holdings in Celldex Therapeutics, Inc. $CLDX https://t.co/x1DRmabnOF
November 19th 2017, 5:11am
TickerReport @TickerReport
Northern Trust Corp Increases Holdings in Celldex Therapeutics, Inc. $CLDX https://t.co/5BClN3Cbpq
November 19th 2017, 5:11am
emq_news @emq_news
Northern Trust Corp Increases Holdings in Celldex Therapeutics, Inc. $CLDX https://t.co/sfj2eYAQkN
November 19th 2017, 5:11am
ledgerzette @ledgerzette
Celldex Therapeutics, Inc. $CLDX Rating Reiterated by HC Wainwright https://t.co/vQQFbDYZgd
November 18th 2017, 5:11pm
dispatchtribune @dispatchtribune
HC Wainwright Reaffirms “Buy” Rating for Celldex Therapeutics, Inc. $CLDX https://t.co/TVjPZqoQpY
November 18th 2017, 4:11pm
stockcharts247 @stockcharts247
CLDX 2.91   -  Updated: 11-18-2017 $CLDX Last Trade: 11/17/2017 Last 2.91   -  Open 2.84 Previous Clos https://t.co/Ok2evweDTG
November 18th 2017, 3:11pm
Farv23060 @Farv23060
$CLDX Feb 16 2018 $3 Calls 11/14 - Buy to Open @ .34 Speculative - Client request https://t.co/sxAtOyRh5a
November 18th 2017, 11:11am
stockcharts247 @stockcharts247
CLDX 2.91   -  Updated: 11-17-2017 $CLDX Last Trade: 11/17/2017 Last 2.91   -  Open 2.84 Previous Clos https://t.co/PIKeJLL7oI
November 17th 2017, 11:11pm
CRWECrownEquity @CRWECrownEquity
$CLDX Initiates Mid-Stage Combination Study of CDX-3379 and Cetuximab in Head and Neck Squamous Cell Carcinoma https://t.co/tfdVyJn10k
November 17th 2017, 3:11pm
rmooney896 @rmooney896
Celldex launches mid-stage study of CDX-3379 in head and neck cancer https://t.co/n054xTirRn $CLDX $LLY
November 17th 2017, 1:11pm
Janfr31 @Janfr31
RT @bdailystocks: $CLDX $2.99 +0.14 (4.91%) - News Out on Celldex Therapeutics https://t.co/HHCFSXGqzP
November 17th 2017, 1:11pm
bdailystocks @bdailystocks
$CLDX $2.99 +0.14 (4.91%) - News Out on Celldex Therapeutics https://t.co/HHCFSXGqzP
November 17th 2017, 1:11pm
mad64318 @mad64318
$CLDX https://t.co/8vq54RSwx0
November 17th 2017, 10:11am
nelsnyc @nelsnyc
$CLDX grabbing some early before the break
November 17th 2017, 9:11am
MarketCurrents @MarketCurrents
Celldex launches mid-stage study of CDX-3379 in head and neck cancer https://t.co/Uj0czOKZp3 $CLDX $LLY
November 17th 2017, 9:11am
SEEKINGALPHA_FS @SEEKINGALPHA_FS
Celldex launches mid-stage study of CDX-3379 in head and neck cancer https://t.co/34BXqsMoDa $CLDX $LLY
November 17th 2017, 9:11am
falsoguaritore @falsoguaritore
$CLDX Celldex Therapeutics Initiates Phase 2 Combination Study of CDX-3379 and Cetuximab in Head and Neck Squamous… https://t.co/9LmtkDtY2o
November 17th 2017, 9:11am
newswelldone @newswelldone
$CLDX: Celldex (CLDX) nitiates Phase 2 Combination Study of CDX-3379 …: https://t.co/EKxxX9psEt
November 17th 2017, 8:11am
Janfr31 @Janfr31
RT @stockboardinc: $CLDX Celldex Therapeutics Initiates Phase 2 Combination Study of CDX-3379 and Cetuximab in Head and Neck ... - https://…
November 17th 2017, 8:11am
stockboardinc @stockboardinc
$CLDX Celldex Therapeutics Initiates Phase 2 Combination Study of CDX-3379 and Cetuximab in Head and Neck ... - https://t.co/3Jr34VPHdA
November 17th 2017, 8:11am
Traderideas1 @Traderideas1
RT @odibro: $CLDX Initiates Phase 2 Combination Study of CDX-3379 and Cetuximab in Head and Neck Squamous Cell Carcinoma https://t.co/WVHNt…
November 17th 2017, 8:11am
odibro @odibro
$CLDX Initiates Phase 2 Combination Study of CDX-3379 and Cetuximab in Head and Neck Squamous Cell Carcinoma https://t.co/WVHNtmZnJN
November 17th 2017, 8:11am
GNWLive @GNWLive
Celldex Therapeutics Initiates Phase 2 Combination Study of CDX-3379 and Cetuximab in Head and Neck $CLDX https://t.co/hS3gHkxFwr
November 17th 2017, 8:11am
Allstocknews @Allstocknews
$CLDX Celldex Therapeutics Initiates Phase 2 Combination Study of CDX-3379 and Cetuximab in Head and Neck Squ From our Stock News Alerts App
November 17th 2017, 8:11am
dispatchtribune @dispatchtribune
Financial Contrast: Celldex Therapeutics $CLDX and Metabolix $YTEN https://t.co/1aDoMUocez
November 17th 2017, 7:11am
dispatchtribune @dispatchtribune
Celldex Therapeutics, Inc. $CLDX Announces Quarterly Earnings Results https://t.co/NdZMelBU3W
November 16th 2017, 8:11pm
stocknewstimes @stocknewstimes
Celldex Therapeutics, Inc. $CLDX Issues Quarterly Earnings Results https://t.co/lBqw9IuZS5
November 16th 2017, 6:11pm
mad64318 @mad64318
$CLDX 3.00?
November 16th 2017, 1:11pm
mad64318 @mad64318
$CLDX easy money baby!
November 16th 2017, 1:11pm
BoardCentral @BoardCentral
$CLDX "Re: price drop - time is the enemy" on InvestorVillage message boards: https://t.co/Ka8DhgcPvn
November 16th 2017, 12:11pm
CostanzTrade @CostanzTrade
$CLDX nice... in long
November 16th 2017, 10:11am
mad64318 @mad64318
$CLDX there we go !! Let’s touch that 200ma
November 16th 2017, 10:11am
stocknewstimes @stocknewstimes
Celldex Therapeutics $CLDX Earning Somewhat Positive News Coverage, Study Shows https://t.co/Ex78booYPQ
November 15th 2017, 7:11pm
SleekMoneycom @SleekMoneycom
Celldex Therapeutics $CLDX Earning Somewhat Positive News Coverage, Study Shows https://t.co/LinI5qLf8n
November 15th 2017, 7:11pm
mad64318 @mad64318
$CLDX lets do this !! I’m in?
November 15th 2017, 3:11pm
alphabetastock @alphabetastock
Early Moves to Watch: Celldex Therapeutics Inc $CLDX https://t.co/BovS6HlZtI
November 15th 2017, 2:11pm
CostanzTrade @CostanzTrade
$CLDX beautiful hourly
November 15th 2017, 10:11am
Janfr31 @Janfr31
RT @falsoguaritore: $CLDX trail update A Study to Evaluate the Safety and Pharmacokinetics of CDX-0158 in Adult Patients With Advanced Soli…
November 15th 2017, 9:11am
falsoguaritore @falsoguaritore
$CLDX trail update A Study to Evaluate the Safety and Pharmacokinetics of CDX-0158 in Adult Patients With Advanced… https://t.co/iJ6V1DLCrO
November 15th 2017, 5:11am
emq_news @emq_news
Celldex Therapeutics, Inc. $CLDX Shares Bought by TIAA CREF Investment Management LLC https://t.co/QZdiqF4VzU
November 14th 2017, 5:11am
TickerReport @TickerReport
Celldex Therapeutics, Inc. $CLDX Shares Bought by TIAA CREF Investment Management LLC https://t.co/DF9pF1h9vn
November 14th 2017, 5:11am
TickerReport @TickerReport
Celldex Therapeutics, Inc. $CLDX Shares Bought by TIAA CREF Investment Management LLC https://t.co/xLHnTf5Nkz
November 14th 2017, 5:11am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.